Ontario can learn from other countries how to better serve patients diagnosed with rare or life-threatening diseases who seek experimental treatments or drugs not covered by OHIP, says an MPP hoping for approval for an advisory committee to find ways to improve the system. “We deal with this all the time,” Progressive Conservative MPP Lisa MacLeod (Nepean-Carleton) said in an interview. Ontario Health Minister Eric Hoskins said the province makes decisions “on the provision of care based on best practice and . an evidence-based approach. We rely on our clinicians and our experts in the medical field to provide us with that advice, and make recommendations in terms of the services and procedures that should be provided” that will have benefits.

Source: thestar October 20, 2016 00:56 UTC